| 000 | 01648 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513031337.0 | ||
| 264 | 0 | _c19950203 | |
| 008 | 199502s 0 0 eng d | ||
| 022 | _a0261-4189 | ||
| 024 | 7 |
_a10.1002/j.1460-2075.1994.tb06938.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchuitemaker, H | |
| 245 | 0 | 0 |
_aProductive HIV-1 infection of macrophages restricted to the cell fraction with proliferative capacity. _h[electronic resource] |
| 260 |
_bThe EMBO journal _cDec 1994 |
||
| 300 |
_a5929-36 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAphidicolin _xpharmacology |
| 650 | 0 | 4 | _aBase Sequence |
| 650 | 0 | 4 | _aCell Cycle |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aDNA, Viral _xanalysis |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 | _aG1 Phase |
| 650 | 0 | 4 | _aHIV Reverse Transcriptase |
| 650 | 0 | 4 |
_aHIV-1 _xgrowth & development |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMacrophages _xdrug effects |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 |
_aMonocytes _xdrug effects |
| 650 | 0 | 4 | _aNucleic Acid Synthesis Inhibitors |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 |
_aProviruses _xgenetics |
| 650 | 0 | 4 |
_aRNA-Directed DNA Polymerase _xmetabolism |
| 650 | 0 | 4 | _aS Phase |
| 650 | 0 | 4 |
_aThymidine _xanalogs & derivatives |
| 650 | 0 | 4 | _aTranscription, Genetic |
| 700 | 1 | _aKootstra, N A | |
| 700 | 1 | _aFouchier, R A | |
| 700 | 1 | _aHooibrink, B | |
| 700 | 1 | _aMiedema, F | |
| 773 | 0 |
_tThe EMBO journal _gvol. 13 _gno. 24 _gp. 5929-36 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/j.1460-2075.1994.tb06938.x _zAvailable from publisher's website |
| 999 |
_c7528636 _d7528636 |
||